Roche to Provide Early Infant Diagnosis HIV/AIDS Tests

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

BioNTech and Gilead Partner for Pumitamig Clinical Trial

BioNTech SE has officially entered into a clinical trial...

Cencora to Acquire American Oncology Network in $2.4 Billion Deal

Cencora has signed a definitive agreement to acquire American...

Merck Acquires Silence Therapeutics for $1.3 Billion

Merck KGaA has entered into an agreement to acquire...
- Advertisement -

Roche has received an exclusive contact from the National Health Laboratory Services in South Africa to provide support for the country’s Early Infant Diagnosis programme, which aims to combat HIV/AIDS in children. Under the contact, Roche will deliver diagnostics in support of the programme, which will use the dried blood sampling technique to diagnose children within the first months of life.  The technique involves preserving a spot of blood on filter paper and sending it to a test centre, eliminating the need for refrigeration and reducing the amount of blood needed to be stored and delivered.  Early diagnosis is vital for children suffering from HIV/AIDS, as appropriate medical care can significantly reduce the chances of developing illnesses.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Related stories

BioNTech and Gilead Partner for Pumitamig Clinical Trial

BioNTech SE has officially entered into a clinical trial...

Cencora to Acquire American Oncology Network in $2.4 Billion Deal

Cencora has signed a definitive agreement to acquire American...

Merck Acquires Silence Therapeutics for $1.3 Billion

Merck KGaA has entered into an agreement to acquire...

5 Functional Medicine Clinics in Denver for a Personalized Approach to Chronic Inflammation

Chronic inflammation underlies a surprisingly wide range of diagnoses:...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »